abc
QUICK LINKS:

FDA Clears Johnson & Johnson Hepatitis C Drug

Created: 11/22/2013 7:50 PM KSTP.com
By: Cassie Hart

Federal regulators have approved a new drug from Johnson & Johnson for use in treating chronic hepatitis C infections.
    
The U.S. Food and Drug Administration said Friday it approved the drug, a protease inhibitor that blocks a protein needed by the virus to replicate.
    
The Johnson & Johnson drug is designed to eliminate hepatitis C, the most common form of the liver-destroying virus. It is a daily pill taken in combination with the long-established drug cocktail used to treat the most common form of the virus.
    
The FDA's decision comes less than a month after an FDA advisory panel voted unanimously in favor of approving the treatment.
    
More than 3 million people in the U.S. have hepatitis C, a blood-borne disease that is blamed for 15,000 deaths a year.

(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
 

Image: MGN Online

Minneapolis/St. Paul

Broken Clouds
52°
66° | 55°
  • Feels like: 52° F
  • Wind: SE 15mph
  • Humidity: 77%
  • Wed A few thunderstorms possible
    66° | 56°
  • Thu Mainly cloudy and rainy
    66° | 46°
  • Fri Rain in the afternoon, windy
    50° | 38°
  • Sat Mix of sun and clouds
    54° | 42°

Video

KSTP NEWS